MedPath

Sigrid Therapeutics AB

🇸🇪Sweden
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:2

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

Multicenter Trial Investigating Performance and Safety of the Medical Device SiPore21®

Not Applicable
Completed
Conditions
Overweight or Obesity
First Posted Date
2023-10-18
Last Posted Date
2024-12-09
Lead Sponsor
Sigrid Therapeutics AB
Target Recruit Count
318
Registration Number
NCT06087822
Locations
🇵🇱

Klimed ul. Jana Pawła II 59 lok. 6U,, Białystok, Poland

🇵🇱

RENEW Clinic ul. Gajowa 29,, Białystok, Poland

🇵🇱

Klimed Bychawa ul. Piłsudskiego 28,, Bychawa, Poland

and more 24 locations

STAR Study Investigating Performance and Safety of the Medical Device SiPore15™

Not Applicable
Completed
Conditions
Prediabetic State
Overweight
PreDiabetes
Type2 Diabetes Mellitus
Pre Diabetes
Obese
Type2 Diabetes
First Posted Date
2019-01-30
Last Posted Date
2019-11-05
Lead Sponsor
Sigrid Therapeutics AB
Target Recruit Count
43
Registration Number
NCT03823027
Locations
🇫🇮

Pihlajalinna Ite, Satucon OY, Kuopio, Finland

🇸🇪

Clinical Trial Consultants, Uppsala, Uppland, Sweden

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.